St. Louis, Missouri, USA
August 27, 2018
To help farmers manage risk and grow a healthy corn crop, Channel is introducing a new seed product lineup that provides enhanced disease tolerance. Channel® Protexus™ corn provides tolerance against five yield-robbing diseases: anthracnose stalk rot, Goss’s wilt and leaf blight, northern corn leaf blight, gray leaf spot and southern rust of corn.
“The new Channel Protexus products provide protection against some of the most financially devastating corn diseases,” says Brett Ochs, Channel Brand Corn Product Manager. “Along with the knowledge and expertise provided by Channel Seedsmen, the disease tolerance provided by Channel Protexus corn is designed to help farmers reduce yield losses associated with corn diseases.”
Channel is introducing the new product lineup during the Farm Progress Show, Aug. 28-30 in Boone, Iowa.
Relative maturity (RM) of the new corn products range from 97-115 RM. The portfolio will be offered in select geographies and treated with Acceleron® Seed Applied Solutions ELITE with Enhanced Disease Control, which reduces infections caused by Fusarium, Rhizoctonia and Colletotrichum (the pathogen that leads to anthracnose stalk rot).
The new corn products are the result of a rigorous selection process using field tested, precision breeding. Through an extensive data-driven breeding program, the Channel Protexus lineup is thoroughly evaluated based on the latest science and field testing to help farmers maximize plant health and yield potential. Farmers can be confident the product line has the best possible genetics and are farm-tested to address the specific challenges they face in their local areas.
Learn more about new Channel Protexus corn at Channel.com.
About Bayer
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2017, the Group employed around 99,800 people and had sales of EUR 35.0 billion. Capital expenditures amounted to EUR 2.4 billion, R&D expenses to EUR 4.5 billion. For more information, go to www.bayer.com.